Moxibustion for pre & stage 1 hypertension: a pilot randomized controlled open trial

INTERVENTION: Medical Device : Treatment A group: 2 times/week, for 4 weeks Treatment B group: 3 times/week, for 4 weeks Control group: non‐treated CONDITION: Diseases of the circulatory system PRIMARY OUTCOME: blood pressure before and after moxibustion treatment SECONDARY OUTCOME: blood test(FBS, uric acid, lipid profile, hs CRP, LFT, HbA1C, CBC) BMI(Body Mass Index) EuroQol(EQ‐5D) Fatigue Severity Scale (FSS) General assessment HRV(Heart Rate Variability) mean of pulse pressure Modified form of the Stress Response Inventory (SRI‐MF) Neck Disability Index(NDI) Pittsburgh Sleep Quality Index(PSQI) Questionnaire of Pattern Identification INCLUSION CRITERIA: 1. patient age between 19 and 65 years 2. Prehypertension or stage 1 hypertension(JNC 7) 3. patients voluntarily participated in this experiment and signed the consent form